Amrutanjan Health Care Fair Value
Amrutanjan Health Care (AMRUTANJAN) average fair value is ₹684.88 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹509.0 (+34.55%), fair value range ₹363.33–₹1006.43.
Fair Value Analysis Export
AMRUTANJAN Fair Value vs Current Price — Valuation Summary
AMRUTANJAN average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Check Amrutanjan Health Care marketcap in USD to track the company's total market size over time.
P/B Based Valuation
Asset-Based Valuation
AMRUTANJAN Fair Value Analysis — Data Sources & Coverage
Amrutanjan Health Care financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Amrutanjan Health Care screener.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
AMRUTANJAN vs Healthcare Sector Peers — P/E, P/B & Market Cap
Amrutanjan Health Care P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Sat Kartar Life | SATKARTAR | 12.78 | 3.19 | ₹221 |
| Jeena Sikho Lifecare | JSLL | 32.14 | 15.26 | ₹6,960 |
| SMS Lifesciences | SMSLIFE | 22.27 | 1.82 | ₹354 |
| Emcure Pharmaceuticals | EMCURE | 38.74 | 7.37 | ₹35,696 |
| Sai Life Sciences | SAILIFE | 78.41 | 11.02 | ₹26,771 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.